Veru Inc Stock EBITDA

VERU Stock

USD 0.49 0.01 2.08%

Veru's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Veru Stock price.

		Last Reported	Projected for Next Year
	EBITDA	-32.6 M	-31 M

EBITDA is likely to gain to about (31 M) in 2025.

Build AI portfolio with Veru Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Veru Inc Company EBITDA Analysis

Veru's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Veru EBITDA

(36.2 M)

Most of Veru's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Veru Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Veru EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Veru is extremely important. It helps to project a fair market value of Veru Stock properly, considering its historical fundamentals such as EBITDA. Since Veru's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Veru's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Veru's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Current Deferred Revenue	Common Stock	Treasury Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Net Invested Capital	Long Term Investments	Net Working Capital	Long Term Debt Total	Short Long Term Debt	Capital Stock
Total Assets		0.92	-0.92	-0.31	0.48	0.13	0.67	0.97	-0.28	0.05	-0.26	0.4	-0.36	0.2	0.66	0.79	0.63	-0.33	-0.43	0.88	-0.1	0.94	-0.59	-0.54	0.28
Total Stockholder Equity	0.92		-0.94	0.01	0.25	0.26	0.34	0.92	-0.14	0.08	-0.15	0.1	-0.3	-0.12	0.36	0.68	0.33	-0.26	-0.33	0.93	0.14	0.93	-0.32	-0.23	0.06
Net Debt	-0.92	-0.94		0.07	-0.34	-0.16	-0.42	-0.97	0.12	0.15	0.09	-0.13	0.11	-0.06	-0.44	-0.76	-0.41	0.3	0.14	-0.96	-0.05	-0.97	0.35	0.34	-0.11
Retained Earnings	-0.31	0.01	0.07		-0.43	0.2	-0.77	-0.25	0.36	0.27	0.29	-0.92	0.26	-0.89	-0.86	-0.58	-0.91	0.39	0.36	0.02	0.53	-0.21	0.79	0.95	-0.87
Accounts Payable	0.48	0.25	-0.34	-0.43		-0.19	0.78	0.44	-0.25	-0.02	-0.21	0.21	-0.18	0.49	0.52	0.3	0.5	-0.2	-0.23	0.16	0.09	0.27	-0.46	-0.58	0.17
Net Receivables	0.13	0.26	-0.16	0.2	-0.19		-0.2	0.18	0.0	-0.18	-0.05	-0.16	-0.37	-0.26	-0.18	0.15	-0.15	-0.3	-0.36	0.21	0.13	0.16	0.12	0.18	-0.15
Total Liab	0.67	0.34	-0.42	-0.77	0.78	-0.2		0.6	-0.41	-0.01	-0.36	0.72	-0.3	0.69	0.91	0.57	0.87	-0.28	-0.41	0.32	-0.35	0.49	-0.84	-0.87	0.58
Total Current Assets	0.97	0.92	-0.97	-0.25	0.44	0.18	0.6		-0.22	-0.14	-0.19	0.31	-0.21	0.2	0.61	0.83	0.58	-0.36	-0.27	0.93	-0.07	0.98	-0.53	-0.5	0.25
Short Term Debt	-0.28	-0.14	0.12	0.36	-0.25	0.0	-0.41	-0.22		-0.18	0.99	-0.37	-0.01	-0.16	-0.46	-0.25	-0.43	0.28	0.16	-0.12	0.17	-0.21	0.43	0.4	-0.31
Intangible Assets	0.05	0.08	0.15	0.27	-0.02	-0.18	-0.01	-0.14	-0.18		-0.23	-0.13	-0.2	-0.48	-0.15	-0.43	-0.24	0.48	-0.24	-0.07	0.22	-0.14	0.07	0.3	-0.29
Current Deferred Revenue	-0.26	-0.15	0.09	0.29	-0.21	-0.05	-0.36	-0.19	0.99	-0.23		-0.32	0.04	-0.09	-0.4	-0.2	-0.36	0.25	0.21	-0.11	0.13	-0.18	0.38	0.33	-0.25
Common Stock	0.4	0.1	-0.13	-0.92	0.21	-0.16	0.72	0.31	-0.37	-0.13	-0.32		-0.32	0.78	0.86	0.6	0.91	-0.37	-0.42	0.12	-0.73	0.31	-0.79	-0.87	0.86
Treasury Stock	-0.36	-0.3	0.11	0.26	-0.18	-0.37	-0.3	-0.21	-0.01	-0.2	0.04	-0.32		-0.08	-0.21	-0.2	-0.23	0.24	0.98	-0.09	0.03	-0.14	0.27	0.21	-0.14
Property Plant Equipment	0.2	-0.12	-0.06	-0.89	0.49	-0.26	0.69	0.2	-0.16	-0.48	-0.09	0.78	-0.08		0.72	0.53	0.82	-0.37	-0.14	-0.05	-0.61	0.14	-0.57	-0.88	0.75
Long Term Debt	0.66	0.36	-0.44	-0.86	0.52	-0.18	0.91	0.61	-0.46	-0.15	-0.4	0.86	-0.21	0.72		0.74	0.97	-0.32	-0.34	0.38	-0.5	0.57	-0.88	-0.93	0.74
Net Tangible Assets	0.79	0.68	-0.76	-0.58	0.3	0.15	0.57	0.83	-0.25	-0.43	-0.2	0.6	-0.2	0.53	0.74		0.8	-0.55	-0.26	0.73	-0.37	0.85	-0.61	-0.74	0.56
Capital Surpluse	0.63	0.33	-0.41	-0.91	0.5	-0.15	0.87	0.58	-0.43	-0.24	-0.36	0.91	-0.23	0.82	0.97	0.8		-0.45	-0.35	0.35	-0.58	0.55	-0.86	-0.98	0.79
Deferred Long Term Liab	-0.33	-0.26	0.3	0.39	-0.2	-0.3	-0.28	-0.36	0.28	0.48	0.25	-0.37	0.24	-0.37	-0.32	-0.55	-0.45		0.28	-0.25	0.22	-0.35	0.48	0.47	-0.38
Accumulated Depreciation	-0.43	-0.33	0.14	0.36	-0.23	-0.36	-0.41	-0.27	0.16	-0.24	0.21	-0.42	0.98	-0.14	-0.34	-0.26	-0.35	0.28		-0.12	0.09	-0.19	0.39	0.32	-0.23
Net Invested Capital	0.88	0.93	-0.96	0.02	0.16	0.21	0.32	0.93	-0.12	-0.07	-0.11	0.12	-0.09	-0.05	0.38	0.73	0.35	-0.25	-0.12		-0.06	0.97	-0.29	-0.24	0.02
Long Term Investments	-0.1	0.14	-0.05	0.53	0.09	0.13	-0.35	-0.07	0.17	0.22	0.13	-0.73	0.03	-0.61	-0.5	-0.37	-0.58	0.22	0.09	-0.06		-0.11	0.37	0.51	-0.44
Net Working Capital	0.94	0.93	-0.97	-0.21	0.27	0.16	0.49	0.98	-0.21	-0.14	-0.18	0.31	-0.14	0.14	0.57	0.85	0.55	-0.35	-0.19	0.97	-0.11		-0.49	-0.45	0.24
Long Term Debt Total	-0.59	-0.32	0.35	0.79	-0.46	0.12	-0.84	-0.53	0.43	0.07	0.38	-0.79	0.27	-0.57	-0.88	-0.61	-0.86	0.48	0.39	-0.29	0.37	-0.49		0.84	-0.71
Short Long Term Debt	-0.54	-0.23	0.34	0.95	-0.58	0.18	-0.87	-0.5	0.4	0.3	0.33	-0.87	0.21	-0.88	-0.93	-0.74	-0.98	0.47	0.32	-0.24	0.51	-0.45	0.84		-0.81
Capital Stock	0.28	0.06	-0.11	-0.87	0.17	-0.15	0.58	0.25	-0.31	-0.29	-0.25	0.86	-0.14	0.75	0.74	0.56	0.79	-0.38	-0.23	0.02	-0.44	0.24	-0.71	-0.81

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Veru

Ebitda Over Time

Veru Ebitda

Ebitda

(30.95 Million)

At this time, Veru's EBITDA is comparatively stable compared to the past year.

According to the company disclosure, Veru Inc reported earnings before interest,tax, depreciation and amortization of (36.2 Million). This is 104.13% lower than that of the Personal Care Products sector and 136.14% lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 100.93% higher than that of the company.

Veru EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Veru's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Veru could also be used in its relative valuation, which is a method of valuing Veru by comparing valuation metrics of similar companies.

Veru is currently under evaluation in ebitda category among its peers.

Veru Institutional Holders

Institutional Holdings refers to the ownership stake in Veru that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Veru's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Veru's value.

		Shares
Rsm Us Wealth Management Llc	2025-03-31	669.3 K
Envestnet Asset Management Inc	2025-03-31	666.3 K
Susquehanna International Group, Llp	2025-03-31	521.1 K
180 Wealth Advisors, Llc	2025-06-30	458.9 K
Boothbay Fund Management, Llc	2025-03-31	405.3 K
Blair William & Co	2025-06-30	380 K
Bank Of New York Mellon Corp	2025-03-31	377 K
Morgan Stanley - Brokerage Accounts	2025-03-31	376.4 K
Charles Schwab Investment Management Inc	2025-03-31	375.3 K
Blackrock Inc	2025-03-31	8.6 M
Mpm Oncology Impact Management Lp	2025-03-31	6.6 M

Veru Fundamentals

	Return On Equity	-0.94
	Return On Asset	-0.49
	Profit Margin	(2.15) %
	Operating Margin	(2.43) %
	Current Valuation	55.36 M
	Shares Outstanding	146.58 M
	Shares Owned By Insiders	14.10 %
	Shares Owned By Institutions	32.74 %
	Number Of Shares Shorted	11.21 M
	Price To Earning	240.00 X
	Price To Book	3.42 X
	Price To Sales	4.28 X
	Revenue	16.89 M
	Gross Profit	5.85 M
	EBITDA	(36.2 M)
	Net Income	(37.8 M)
	Cash And Equivalents	100.55 M
	Cash Per Share	1.25 X
	Total Debt	13.86 M
	Debt To Equity	0.17 %
	Current Ratio	4.62 X
	Book Value Per Share	0.14 X
	Cash Flow From Operations	(21.68 M)
	Short Ratio	4.61 X
	Earnings Per Share	(0.22) X
	Target Price	3.33
	Number Of Employees	210
	Beta	-0.74
	Market Capitalization	72.34 M
	Total Asset	60.42 M
	Retained Earnings	(294.57 M)
	Working Capital	23.36 M
	Current Asset	15.14 M
	Current Liabilities	4.19 M
	Five Year Return	3.55 %
	Net Asset	60.42 M

About Veru Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Veru Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Veru using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Veru Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veru Stock Analysis

When running Veru's price analysis, check to measure Veru's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veru is operating at the current time. Most of Veru's value examination focuses on studying past and present price action to predict the probability of Veru's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veru's price. Additionally, you may evaluate how the addition of Veru to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC